Drug intelligence / Profile preview

Canatrex

Development stage
Unknown
Lead developer
CBH International
Modality
Small Molecules
Administration
Topical
01

Overview

Canatrex is a proprietary hemp-based formulation developed by CBH International, LLC, primarily utilized in the Uncle Bud's line of topical pain relief and skincare products. It consists of a specialized blend of pure hemp seed oil (*Cannabis sativa* seed oil) combined with other supplements, moisturizers, and therapeutic ingredients. The formulation is designed to leverage the anti-inflammatory and moisturizing properties of hemp seed oil, which is rich in omega-3, omega-6, and omega-9 fatty acids, as well as antioxidants and vitamins. Canatrex is incorporated into various over-the-counter (OTC) topical analgesics and skincare items intended to relieve minor aches and pains associated with arthritis, muscle soreness, and joint stiffness. In many of its analgesic applications, Canatrex serves as a delivery system or therapeutic base for active pharmaceutical ingredients such as trolamine salicylate or methyl salicylate, which provide localized pain relief by inhibiting prostaglandin synthesis.

Brand names
Uncle Bud's
Other names
Canatrex Plus
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Canatrex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canatrex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call